ConMed Corp (CNMD):企業の財務・戦略的SWOT分析

◆英語タイトル:ConMed Corp (CNMD) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14212
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ConMed Corp (CNMD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ConMed Corp (ConMed) is a medical technology company which manufactures and sells surgical devices and instruments for minimally invasive procedures and monitoring. The company’s major products include arthroscopes, reconstructive systems, bronchoscopy devices endoscopic ligator kit, stone removal balloon, trocars, graspers, scissors, suction irrigation devices, thermal tissue fusion system, electrosurgical generators, smoke evacuation pencil, pencil sheath, saws, blades, endomechanical instrumentation, and surgical visualization equipment. ConMed caters its products to orthopedic, general surgery, gynecology, gastroenterology, pulmonology, anesthesiology and sports medicine markets. The company sells its products through direct sales force and medical specialty distributors. It operates in the Americas, Europe, Middle East and Asia-Pacific. ConMed is headquartered in New York, the US.

ConMed Corp Key Recent Developments

Jan 22,2019: CONMED announces fourth quarter and full-year 2018 financial results
Dec 17,2018: Conmed to buy medical products firm Buffalo Filter for $365m
Nov 05,2018: CONMED Corporation to Present at the Jefferies London Healthcare Conference
Nov 01,2018: CONMED announces third quarter 2018 financial results
Aug 01,2018: CONMED announces second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ConMed Corp – Key Facts
ConMed Corp – Key Employees
ConMed Corp – Key Employee Biographies
ConMed Corp – Major Products and Services
ConMed Corp – History
ConMed Corp – Company Statement
ConMed Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ConMed Corp – Business Description
Product Category: General Surgery
Overview
Performance
Product Category: Orthopedic Surgery
Overview
Performance
Geographical Segment: Americas (excluding the US)
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East & Africa
Performance
Geographical Segment: United States
Performance
R&D Overview
ConMed Corp – Corporate Strategy
ConMed Corp – SWOT Analysis
SWOT Analysis – Overview
ConMed Corp – Strengths
ConMed Corp – Weaknesses
ConMed Corp – Opportunities
ConMed Corp – Threats
ConMed Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ConMed Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
ConMed Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
ConMed Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 22, 2019: CONMED announces fourth quarter and full-year 2018 financial results
Dec 17, 2018: Conmed to buy medical products firm Buffalo Filter for $365m
Nov 01, 2018: CONMED announces third quarter 2018 financial results
Aug 01, 2018: CONMED announces second quarter 2018 financial results
Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results
Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results
Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ConMed Corp, Key Facts
ConMed Corp, Key Employees
ConMed Corp, Key Employee Biographies
ConMed Corp, Major Products and Services
ConMed Corp, History
ConMed Corp, Other Locations
ConMed Corp, Subsidiaries
ConMed Corp, Key Competitors
ConMed Corp, Ratios based on current share price
ConMed Corp, Annual Ratios
ConMed Corp, Annual Ratios (Cont...1)
ConMed Corp, Annual Ratios (Cont...2)
ConMed Corp, Interim Ratios
ConMed Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
ConMed Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019
ConMed Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ConMed Corp, Performance Chart (2014 - 2018)
ConMed Corp, Ratio Charts
ConMed Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019
ConMed Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[ConMed Corp (CNMD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cosmo Pharmaceuticals NV (COPN):企業の財務・戦略的SWOT分析
    Summary Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix technology. Its proprietary clinical development pipeline intended for the treatment of …
  • Multiplicom NV-医療機器分野:企業M&A・提携分析
    Summary Multiplicom NV (Multiplicom) is a molecular diagnostic company that develops, manufactures and markets genetic test kits. The company offers onco genetics, human genetics and prenatal genetics products. Its human genetics products are used for cancer genetics, genetic disorders and neurologi …
  • HeartWare International Inc:企業の製品パイプライン分析2018
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc, is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that c …
  • Piramal Enterprises Ltd (PEL):製薬・医療:M&Aディール及び事業提携情報
    Summary Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. I …
  • Ultragenyx Pharmaceutical Inc (RARE):医療機器:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • AusNet Services Ltd (AST):企業の財務・戦略的SWOT分析
    AusNet Services Ltd (AST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Baloise Holding Ltd (BALN):企業の財務・戦略的SWOT分析
    Baloise Holding Ltd (BALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Jadranka dd:企業の戦略・SWOT・財務分析
    Jadranka dd - Strategy, SWOT and Corporate Finance Report Summary Jadranka dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Steel Reef Infrastructure Corp-石油・ガス分野:企業M&A・提携分析
    Summary Steel Reef Infrastructure Corp (Steel Reef) is a mid-stream company that focuses on long-term returns through investments in small to midsized infrastructure with focus on the Western Canadian Sedimentary Basin. The company carries out the construction, operation and optimization of oil and …
  • GE Lighting LLC:企業の戦略的SWOT分析
    GE Lighting LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian …
  • Formosa Petrochemical Corp (6505):企業の財務・戦略的SWOT分析
    Formosa Petrochemical Corp (6505) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Continental AG:企業の戦略・SWOT・財務分析
    Continental AG - Strategy, SWOT and Corporate Finance Report Summary Continental AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (ATNM), formerly Cactus Ventures Inc is a biopharmaceutical company that provides development of cancer immunotherapies. The company provides pipeline products such as Iomab-B that is used for hematopoietic stem cells transplantation. It provides Iomab-B through …
  • Hemispherx Biopharma Inc (HEB):医療機器:M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • Exact Sciences Corp (EXAS)-医療機器分野:企業M&A・提携分析
    Summary Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of …
  • Saudi Kayan Petrochemical Co (2350):企業の財務・戦略的SWOT分析
    Summary Saudi Kayan Petrochemical Co (Saudi Kayan) is a petrochemical company that manufactures and markets specialty chemicals. The company offers products such as ethanolamines, ethoxylates, phenol, cumene, polycarbonate, ethylene, propylene, polyethylene, monoethanolamine, diethanolamine, trietha …
  • Rand Worldwide Inc (RWWI):企業の財務・戦略的SWOT分析
    Summary Rand Worldwide Inc (Rand Worldwide) is a technology company that offers engineering design and information technology solutions. The company operates through divisions such as IMAGINiT technologies, ASCENT-center for technical knowledge, and Rand 3D. It provides 3D design engineering softwar …
  • Genalyte Inc-医療機器分野:企業M&A・提携分析
    Summary Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the …
  • Enstar Group Ltd.:企業の戦略・SWOT・財務情報
    Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆